Evidence-based treatment of Tourette’s disorder and chronic tic disorders

References

• American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5®). American Psychiatric Pub: Washington, DC; 2013.
   Google Scholar
• Kurlan R, Como PG, Miller B, et al. The behavioral spectrum of tic disorders: A community-based study. Neurology. 2002;59:414–420.
   PubMed Web of Science ®Google Scholar
• Robertson MM. The prevalence and epidemiology of Gilles de la Tourette syndrome: part 1: the epidemiological and prevalence studies. J Psychosom Res. 2008;65:461–472.
   PubMed Web of Science ®Google Scholar
• Wu MS, McGuire JF. Psychoeducation about tic disorders and treatment, in the clinician’s guide to treatment and management of youth with Tourette syndrome and tic disorders. Academic Press: Cambridge (MA); 2018. p. 21–41.
   Google Scholar
• Scharf JM, Miller LL, Gauvin CA, et al. Population prevalence of Tourette syndrome: A systematic review and meta‐analysis. Mov Disord. 2015;30:221–228.
   PubMed Web of Science ®Google Scholar
• Scahill L, Sukhodolsky DG, Williams SK, et al. Public health significance of tic disorders. Behav Neurol Mov Disord. 2005;96:240.
   Google Scholar
• Knight, T., T. Steeves, L. Day, et al. Prevalence of tic disorders: a systematic review and meta-analysis. Pediatr neurol. 2012;47:77–90.
   PubMed Web of Science ®Google Scholar
• Scahill L, Specht M, Page C. The prevalence of tic disorders and clinical characteristics in children. J Obsessive Compuls Relat Disord. 2014;3:394–400.
   PubMed Web of Science ®Google Scholar
• Leckman JF, Zhang H, Vitale A, et al. Course of tic severity in Tourette syndrome: the first two decades. Pediatr English Ed. 1998;102:14–19.
   PubMed Web of Science ®Google Scholar
• McGuire JF, Nyirabahizi E, Kircanski K, et al. A cluster analysis of tic symptoms in children and adults with Tourette syndrome: clinical correlates and treatment outcome. Psychiatry Res. 2013;210:1198–1204.
   PubMed Web of Science ®Google Scholar
• Freeman RD, Zinner SH, MÜLLER‐VAHL KR, et al. Coprophenomena in Tourette syndrome. Dev Med Child Neurol. 2009;51:218–227.
   PubMed Web of Science ®Google Scholar
• Bloch MH, Peterson BS, Scahill L, et al. Adulthood outcome of tic and obsessive-compulsive symptom severity in children with Tourette syndrome. Arch Pediatr Adolesc Med. 2006;160:65–69.
   PubMedGoogle Scholar
• Groth C, Debes NM, Rask CU, et al. Course of Tourette syndrome and comorbidities in a large prospective clinical study. J Am Acad Child Adolesc Psychiatry. 2017;56:304–312.
   PubMed Web of Science ®Google Scholar
• Leckman JF, Walker DE, Cohen DJ. Premonitory urges in Tourette’s syndrome. Am J Psychiatry. 1993;150: 98–102.
   Web of Science ®Google Scholar
• Banaschewski T, Woerner W, Rothenberger A. Premonitory sensory phenomena and suppressibility of tics in Tourette syndrome: developmental aspects in children and adolescents. Dev Med Child Neurol. 2003;45:700–703.
   PubMed Web of Science ®Google Scholar
• McGuire JF, McBride N, Piacentini J, et al. The premonitory urge revisited: an individualized premonitory urge for tics scale. J Psychiatr Res. 2016;83:176–183.
   PubMed Web of Science ®Google Scholar
• Woods DW, Piacentini J, Himle MB, et al. Premonitory Urge for Tics Scale (PUTS): initial psychometric results and examination of the premonitory urge phenomenon in youths with tic disorders. J Dev Behav Pediatr. 2005;26:397–403.
   PubMed Web of Science ®Google Scholar
• Freeman RD, Fast DK, Burd L, et al. An international perspective on Tourette syndrome: selected findings from 3500 individuals in 22 countries. Dev Med Child Neurol. 2000;42:436–447.
   PubMed Web of Science ®Google Scholar
• McGuire JF, Murphy TK, Piacentini J, et al. Introduction to treatment and management of youth with Tourette disorders and tic disorders, in the clinician’s guide to treatment and management of youth with Tourette Syndrome and tic disorders. Academic Press: Cambridge (MA); 2018. p. 1–20.
   Google Scholar
• Storch EA, Lack CW, Simons LE, et al. A measure of functional impairment in youth with Tourette’s syndrome. J Pediatr Psychol. 2007;32:950–959.
   PubMed Web of Science ®Google Scholar
• Cloes KI, Barfell KSF, Horn PS, et al. Preliminary evaluation of child self‐rating using the child Tourette Syndrome impairment scale. Dev Med Child Neurol. 2017;59:284–290.
   PubMed Web of Science ®Google Scholar
• Hanks CE, McGuire JF, Lewin AB, et al. Clinical correlates and mediators of self-concept in youth with chronic tic disorders. Child Psychiatry Human Dev. 2016;47:64–74.
   PubMed Web of Science ®Google Scholar
• Storch EA, Johnco C, McGuire JF, et al. An initial study of family accommodation in children and adolescents with chronic tic disorders. Eur Child Adolesc Psychiatry. 2017;26:99–109.
   PubMed Web of Science ®Google Scholar
• Conelea CA, Woods DW, Zinner SH, et al. Exploring the impact of chronic tic disorders on youth: results from the Tourette syndrome impact survey. Child Psychiatry Hum Dev. 2011;42:219–242.
   PubMed Web of Science ®Google Scholar
• Storch EA, Merlo LJ, Lack C, et al. Quality of life in youth with Tourette’s syndrome and chronic tic disorder. J Clin Child Adolesc Psychol. 2007;36:217–227.
   PubMed Web of Science ®Google Scholar
• Cutler D, Murphy T, Gilmour J, et al. The quality of life of young people with Tourette syndrome. Child Care Health Dev. 2009;35:496–504.
   PubMed Web of Science ®Google Scholar
• Conelea CA, Woods DW, Zinner SH, et al. The impact of Tourette syndrome in adults: results from the Tourette syndrome impact survey. Community Ment Health J. 2013;49:110–120.
   PubMed Web of Science ®Google Scholar
• Woods DW, Piacentini J, Chang SW, et al. Managing Tourette Syndrome: A behavioral intervention for children and adolescents. Treatments that work. New York: Oxford University Press; 2008.
   Google Scholar
• Himle MB, Woods DW, Conelea CA, et al. Investigating the effects of tic suppression on premonitory urge ratings in children and adolescents with Tourette’s syndrome. Behav Res Ther. 2007;45:2964–2976.
   PubMed Web of Science ®Google Scholar
• Capriotti MR, Brandt BC, Turkel JE, et al. Negative reinforcement and premonitory urges in youth with Tourette syndrome an experimental evaluation. Behav Modif. 2014;38:276–296.
   PubMed Web of Science ®Google Scholar
• Specht MW, Woods DW, Nicotra CM, et al. Effects of tic suppression: ability to suppress, rebound, negative reinforcement, and habituation to the premonitory urge. Behav Res Ther. 2013;51:24–30.
   PubMed Web of Science ®Google Scholar
• Himle MB, Capriotti MR, Hayes LP, et al. Variables associated with tic exacerbation in children with chronic tic disorders. Behav Modif. 2014;38:163–183.
   PubMed Web of Science ®Google Scholar
• Capriotti MR, Piacentini JC, Himle MB, et al. Assessing environmental consequences of ticcing in youth with chronic tic disorders: the tic accommodation and reactions scale. Children’s Health Care. 2015;44:205–220.
   PubMed Web of Science ®Google Scholar
• Azrin N, Nunn R. Habit-reversal: a method of eliminating nervous habits and tics. Behav Res Ther. 1973;11:619–628.
   PubMed Web of Science ®Google Scholar
• McGuire JF, Ricketts EJ, Piacentini J, et al. Behavior therapy for tic disorders: an evidenced-based review and new directions for treatment research. Curr Dev Disord Rep. 2015;2:309–317.
   PubMedGoogle Scholar
• Woods D, Miltenberger R, Lumley V. Sequential application of major habit-reversal components to treat motor tics in children. J Appl Behav Anal. 1995;29:483–493.
   Web of Science ®Google Scholar
• Prabhakar D. Behavioral management of Tourette’s disorder in a 5-year-old child. Prim Care Companion CNS Disord. 2014;16.
   PubMedGoogle Scholar
• McGuire JF, Piacentini J, Brennan EA, et al. A meta-analysis of behavior therapy for Tourette syndrome. J Psychiatr Res. 2014;50:106–112.
   PubMed Web of Science ®Google Scholar
• O’Connor K, Brault M, Robillard S, et al. Evaluation of a cognitive-behavioural program for the management of chronic tic and habit disorders. Behav Res Ther. 2001;39:667–681.
   PubMed Web of Science ®Google Scholar
• Azrin NH, Peterson AL. Treatment of Tourette syndrome by habit reversal: A waiting-list control group comparison. Behav Ther. 1990;21:305–318.
   Web of Science ®Google Scholar
• Azrin NH, Nunn RG, Frantz S. Treatment of hairpulling (trichotillomania): a comparative study of habit reversal and negative practice training. J Behav Ther Exp Psychiatry. 1980;11:13–20.
   Web of Science ®Google Scholar
• Verdellen CW, Keijsers GP, Cath DC, et al. Exposure with response prevention versus habit reversal in Tourettes’s syndrome: a controlled study. Behav Res Ther. 2004;42:501–511.
   PubMed Web of Science ®Google Scholar
• Wilhelm S, Deckersbach T, Coffey BJ, et al. Habit reversal versus supportive psychotherapy for Tourette’s disorder: a randomized controlled trial. Am J Psychiatry. 2003;160:1175–1177.
   PubMed Web of Science ®Google Scholar
• Deckersbach T, Rauch S, Buhlmann U, et al. Habit reversal versus supportive psychotherapy in Tourette’s disorder: a randomized controlled trial and predictors of treatment response. Behav Res Ther. 2006;44:1079–1090.
   PubMed Web of Science ®Google Scholar
• Yates R, Edwards K, King J, et al. Habit reversal training and educational group treatments for children with tourette syndrome: a preliminary randomised controlled trial. Behav Res Ther. 2016;80:43–50.
   PubMed Web of Science ®Google Scholar
• Rizzo R, Pellico A, Silvestri PR, et al. A Randomized controlled trial comparing behavioral, educational, and pharmacological treatments in youths with chronic tic disorder or tourette syndrome. Front Psychiatry. 2018;9:100.
   PubMed Web of Science ®Google Scholar
• van de Griendt JM, van Dijk MK, Verdellen CW, et al. The effect of shorter exposure versus prolonged exposure on treatment outcome in Tourette syndrome and chronic tic disorders–an open trial. Int J Psychiatry Clin Pract. 2018;22:262–267.
   PubMed Web of Science ®Google Scholar
• Dabrowski J, King J, Edwards K, et al. The long-term effects of group-based psychological interventions for children with Tourette syndrome: a randomized controlled trial. Behav Ther. 2018;49:331–343.
   PubMed Web of Science ®Google Scholar
• Ricketts EJ, Goetz AR, Capriotti MR, et al. A randomized waitlist-controlled pilot trial of voice over Internet protocol-delivered behavior therapy for youth with chronic tic disorders. J Telemed Telecare. 2016;22:153–162.
   PubMed Web of Science ®Google Scholar
• Piacentini J, Woods DW, Scahill L, et al. Behavior therapy for children with Tourette disorder: A randomized controlled trial. J Am Med Assoc. 2010;303:1929–1937.
   PubMed Web of Science ®Google Scholar
• Wilhelm S, Peterson AL, Piacentini J, et al. Randomized trial of behavior therapy for adults with Tourette syndrome. Arch Gen Psychiatry. 2012;69:795–803.
   PubMed Web of Science ®Google Scholar
• Peterson AL, McGuire JF, Wilhelm S, et al. An empirical examination of symptom substitution associated with behavior therapy for Tourette’s Disorder. Behav Ther. 2016;47:29–41.
   PubMed Web of Science ®Google Scholar
• Woods DW, Piacentini JC, Scahill L, et al. Behavior therapy for tics in children: acute and long-term effects on psychiatric and psychosocial functioning. J Child Neurol. 2011;26:858–865.
   PubMed Web of Science ®Google Scholar
• McGuire JF, Ricketts EJ, Scahill L, et al., Effect of Behavior Therapy for Tourette’s Disorder on Psychiatric Symptoms and Functioning. 2019
   Google Scholar
• Conelea CA, Woods DW, Brandt BC. The impact of a stress induction task on tic frequencies in youth with Tourette syndrome. Behav Res Ther. 2011;49:492–497.
   PubMed Web of Science ®Google Scholar
• Verdellen CW, Hoogduin CA, Kato BS, et al. Habituation of premonitory sensations during exposure and response prevention treatment in Tourette’s syndrome. Behav Modif. 2008;32:215–227.
   PubMed Web of Science ®Google Scholar
• Verdellen CW, Hoogduin CA, Keijsers GP. Tic suppression in the treatment of Tourette’s syndrome with exposure therapy: the rebound phenomenon reconsidered. Mov Disord. 2007;22:1601–1606.
   PubMed Web of Science ®Google Scholar
• Hall CL, Davies EB, Andrén P, et al. Investigating a therapist-guided, parent-assisted remote digital behavioural intervention for tics in children and adolescents—‘online remote behavioural intervention for tics’(ORBIT) trial: protocol of an internal pilot study and single-blind randomised controlled trial. BMJ Open. 2019;9:e027583.
   PubMed Web of Science ®Google Scholar
• Augustine F, Singer HS. Merging the pathophysiology and pharmacotherapy of tics. Tremor Other Hyperkinet Mov. 2018;8.
   Web of Science ®Google Scholar
• Peters SK, Dunlop K, Downar J. Cortico-striatal-thalamic loop circuits of the salience network: a central pathway in psychiatric disease and treatment. Front Syst Neurosci. 2016;10:104.
   PubMed Web of Science ®Google Scholar
• Pringsheim T, Okun MS, Müller-Vahl K, et al. Practice guideline recommendations summary: treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology. 2019;92:896–906.
   PubMed Web of Science ®Google Scholar
• McGuire J, Hanks C, Murphy T, et al. Pharmacological and behavioral management of Tourette disorder and chronic tic disorders. Minerva Psichiatrica. 2014;55:161–180.
   Google Scholar
• Singer HS. Treatment of tics and tourette syndrome. Curr Treat Options Neurol. 2010;12:539–561.
   PubMed Web of Science ®Google Scholar
• Weisman H, Qureshi IA, Leckman JF, et al. Systematic review: pharmacological treatment of tic disorders - Efficacy of antipsychotic and alpha-2 adrenergic agonist agents. Neurosci Biobehav Rev. 2013;37:1162–1171.
   PubMed Web of Science ®Google Scholar
• Liu Y, Ni H, Wang C, et al. Effectiveness and tolerability of aripiprazole in children and adolescents with Tourette’s disorder: a meta-analysis. J Child Adolesc Psychopharmacol. 2016;26:436–441.
   PubMed Web of Science ®Google Scholar
• Yang CS, Zhang LL, Zeng LN, et al. Topiramate for Tourette’s syndrome in children: A meta-analysis. Pediatr Neurol. 2013;49:344–350.
   PubMed Web of Science ®Google Scholar
• Leckman JF, Riddle MA, Hardin MT, et al. The yale global tic severity scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry. 1989;28:566–573.
   PubMed Web of Science ®Google Scholar
• McGuire JF, Kugler BB, Park JM, et al. Evidence-based assessment of compulsive skin picking, chronic tic disorders and trichotillomania in children. Child Psychiatry Human Dev. 2012;43:855–883.
   PubMed Web of Science ®Google Scholar
• Cubo E, González M, Singer H, et al. Impact of placebo assignment in clinical trials of tic disorders. Mov Disord. 2013;28:1288–1292.
   PubMed Web of Science ®Google Scholar
• Sallee F, Kohegyi E, Zhao J, et al. Randomized, double-blind, placebo-controlled trial demonstrates the efficacy and safety of oral aripiprazole for the treatment of Tourette’s disorder in children and adolescents. J Child Adolesc Psychopharmacol. 2017;27:771–781.
   PubMed Web of Science ®Google Scholar
• Yoo HK, Joung YS, Lee JS, et al. A multicenter, randomized, double-blind, placebo-controlled study of aripiprazole in children and adolescents with Tourette’s disorder. J Clin Psychiatry. 2013;74:e772–e80.
   PubMed Web of Science ®Google Scholar
• Scahill L, Leckman JF, Schultz RT, et al. A placebo-controlled trial of risperidone in Tourette syndrome. Neurology. 2003;60:1130–1135.
   PubMed Web of Science ®Google Scholar
• Singer HS, Brown J, Quaskey S, et al. The treatment of attention-deficit hyperactivity disorder in Tourette’s syndrome: A double-blind placebo-controlled study with clonidine and desipramine. Pediatrics. 1995;95:74–81.
   PubMed Web of Science ®Google Scholar
• Scahill L, Chappell PB, Kim YS, et al. A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. Am J Psychiatry. 2001.
   PubMed Web of Science ®Google Scholar
• Group, T.s.S.S. Treatment of ADHD in children with tics: a randomized controlled trial. Neurology. 2002;58:527.
   PubMed Web of Science ®Google Scholar
• Murphy TK, Lewin AB, Storch EA, et al. Practice parameter for the assessment and treatment of children and adolescents with tic disorders. J Am Acad Child Adolesc Psychiatry. 2013;52:1341–1359.
   PubMed Web of Science ®Google Scholar
• Roessner V, Plessen KJ, Rothenberger A, et al. European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment. Eur Child Adolesc Psychiatry. 2011;20:173–196.
   PubMed Web of Science ®Google Scholar
• Verdellen C, Van De Griendt J, Hartmann A, et al. European clinical guidelines for Tourette syndrome and other tic disorders. Part III: behavioural and psychosocial interventions. Eur Child Adolesc Psychiatry. 2011;20:197–207.
   PubMed Web of Science ®Google Scholar
• Pringsheim T, Doja A, Gorman D, et al. Canadian guidelines for the evidence-based treatment of tic disorders: pharmacotherapy. Can J Psychiatry. 2012;57:133–143.
   PubMed Web of Science ®Google Scholar
• Steeves T, McKinlay BD, Gorman D, et al. Canadian guidelines for the evidence-based treatment of tic disorders: behavioural therapy, deep brain stimulation, and transcranial magnetic stimulation. Can J Psychiatry. 2012;57:144–151.
   PubMed Web of Science ®Google Scholar
• Zhong YQ, Zhou WZ, Hu WG. [Randomized double-blind controlled study on treatment of tic disorders in children with transcutaneous patch of clonidine]. Chin J Pediatr. 2007;45:785–787. Zhonghua er ke za zhi
   Google Scholar
• Leckman JF, Hardin MT, Riddle MA, et al. Clonidine treatment of Gilles de la Tourette’s syndrome. Arch Gen Psychiatry. 1991;48:324–328.
   PubMed Web of Science ®Google Scholar
• Du YS, Li HF, Vance A, et al. Randomized double-blind multicentre placebo-controlled clinical trial of the clonidine adhesive patch for the treatment of tic disorders. Aust N Z J Psychiatry. 2008;42:807–813.
   PubMed Web of Science ®Google Scholar
• Goetz CG, Tanner CM, Wilson RS, et al. Clonidine and Gilles de la Tourette’s syndrome: double‐blind study using objective rating methods. Ann Neurol. 1987;21:307–310.
   PubMed Web of Science ®Google Scholar
• Kang H, Zhang YF, Jiao FY, et al. Efficacy of clonidine transdermal patch for treatment of Tourette’s syndrome in children. Chin J Contemp Pediatr. 2009;11:537–539.
   Google Scholar
• Jiao F, Zhang X, Zhang X, et al. Clinical observation on treatment of Tourette syndrome in Chinese children by clonidine adhesive patch. Eur J Paediatr Neurol. 2016;20:80–84.
   PubMed Web of Science ®Google Scholar
• Zhang H, Lin Y, Liu M, et al. Clinical trial of the clonidine adhesive patch for the treatment of tic disorders. J Pediatr Pharm. 2006;12:8–16.
   Google Scholar
• Guo J-M, Shi -X-X, Yang S-W, et al. [Efficacy of clonidine transdermal patch in treatment of moderate to severe tic disorders in children]. Zhongguo Dang Dai Er Ke Za Zhi. 2017;19:786–789.
   PubMedGoogle Scholar
• Hedderick EF, Morris CM, Singer HS. Double-blind, crossover study of clonidine and levetiracetam in Tourette syndrome. Pediatr Neurol. 2009;40:420–425.
   PubMed Web of Science ®Google Scholar
• Gaffney GR, Perry PJ, Lund BC, et al. Risperidone versus clonidine in the treatment of children and adolescents with Tourette’s syndrome. J Am Acad Child Adolesc Psychiatry. 2002;41:330–336.
   PubMed Web of Science ®Google Scholar
• Lu J, Comparative study in treatment of tic disorders by clonidine and tiapride. China National Knowledge Infrastructure (CNKI). Unknown
   Google Scholar
• Cummings DD, Singer HS, Krieger M, et al. Neuropsychiatric effects of guanfacine in children with mild Tourette syndrome: A pilot study. Clin Neuropharmacol. 2002;25:325–332.
   PubMed Web of Science ®Google Scholar
• Murphy TK, Fernandez TV, Coffey BJ, et al. Extended-release guanfacine does not show a large effect on tic severity in children with chronic tic disorders. J Child Adolesc Psychopharmacol. 2017;27:762–770.
   PubMed Web of Science ®Google Scholar
• Mogwitz S, Buse J, Wolff N, et al. Update on the pharmacological treatment of tics with dopamine-modulating agents. ACS Chem Neurosci. 2018;9:651–672.
   PubMed Web of Science ®Google Scholar
• Ghanizadeh A, Haghighi A. Aripiprazole versus risperidone for treating children and adolescents with tic disorder: a randomized double blind clinical trial. Child Psychiatry Human Dev. 2014;45:596–603.
   PubMed Web of Science ®Google Scholar
• Wang Y, Chen Z, Wang X. The efficacy of aripiprazole and tiapride for Tourette disorders in children. Shandong Med J. 2013;53:58–59.
   Google Scholar
• Zhang H, Huang H, Lin G. A randomized, controlled study of aripiprazole and risperidone for tic disorders. Clin Focus. 2015;30:1393–1396.
   Google Scholar
• Dion Y, Annable L, Sandor P, et al. Risperidone in the treatment of Tourette syndrome: A double-blind, placebo-controlled trial. J Clin Psychopharmacol. 2002;22:31–39.
   PubMed Web of Science ®Google Scholar
• Bruggeman R, Van der Linden C, Buitelaar JK, et al. Risperidone versus pimozide in Tourette’s disorder: A comparative double-blind parallel-group study. J Clin Psychiatry. 2001;62:50–56.
   PubMed Web of Science ®Google Scholar
• Gilbert DL, Batterson JR, Sethuraman G, et al. Tic reduction with risperidone versus pimozide in a randomized, double-blind, crossover trial. J Am Acad Child Adolesc Psychiatry. 2004;43:206–214.
   PubMed Web of Science ®Google Scholar
• Sallee FR, Kurlan R, Goetz CG, et al. Ziprasidone treatment of children and adolescents with Tourette’s syndrome: A pilot study. J Am Acad Child Adolesc Psychiatry. 2000;39:292–299.
   PubMed Web of Science ®Google Scholar
• Shapiro E, Shapiro AK, Fulop G, et al. Controlled study of haloperidol, pimozide, and placebo for the treatment of Gilles de la Tourette’s syndrome. Arch Gen Psychiatry. 1989;46:722–730.
   PubMed Web of Science ®Google Scholar
• Sallee FR, Nesbitt L, Jackson C, et al. Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette’s disorder. Am J Psychiatry. 1997;154:1057–1062.
   PubMed Web of Science ®Google Scholar
• Ross MS, Moldofsky H. A comparison of pimozide and haloperidol in the treatment of Gilles de la Tourette’s syndrome. Am J Psychiatry. 1978;135:585-7.
   PubMed Web of Science ®Google Scholar
• Yang Z-J. The therapeutic efficacy and safety of tiapride and haloperidol in treatment of Tourette syndrome [J]. J Clin Pediatr. 2012;30:1051-3.
   PubMedGoogle Scholar
• Shapiro AK, Shapiro E. Controlled study of pimozide vs. placebo in Tourette’s syndrome. J Am Acad Child Adolesc Psychiatry. 1984;23:161–173.
   Web of Science ®Google Scholar
• Gilbert DL, Murphy TK, Jankovic J, et al. Ecopipam, a D1 receptor antagonist, for treatment of tourette syndrome in children: A randomized, placebo‐controlled crossover study. Mov Disord. 2018;33:1272–1280.
   PubMed Web of Science ®Google Scholar
• Jankovic J, Jimenez-Shahed J, Brown LW. A randomised, double-blind, placebo-controlled study of topiramate in the treatment of Tourette syndrome. J Neurol Neurosurg Psychiatry. 2010;81:70–73.
   PubMed Web of Science ®Google Scholar
• Smith-Hicks CL, Bridges DD, Paynter NP, et al. A double blind randomized placebo control trial of levetiracetam in Tourette syndrome. Mov Disord. 2007;22:1764–1770.
   PubMed Web of Science ®Google Scholar
• Singer HS, Wendlandt J, Krieger M, et al. Baclofen treatment in Tourette syndrome: A double-blind, placebo-controlled, crossover trial. Neurology. 2001;56:599–604.
   PubMed Web of Science ®Google Scholar
• Sharp AN, Singer HS. Standard, complementary, and future treatment options for tics. Curr Dev Disord Rep. 2018;5:101–7.
   PubMedGoogle Scholar
• Martino D, Pringsheim TM. Tourette syndrome and other chronic tic disorders: an update on clinical management. Expert Rev Neurother. 2018;18:125–137.
   PubMed Web of Science ®Google Scholar
• Selles RR, Jukes T, McConnell M, et al. Relapse Prevention Strategies And Guidance On Refractory Cases, In The Clinician’s Guide To Treatment And Management Of Youth with Tourette Syndrome and tic disorders. Academic Press: Cambridge (MA); 2018. p. 347–374.
   Google Scholar
• Martinez-Ramirez D, Jimenez-Shahed J, Leckman JF, et al. Efficacy and safety of deep brain stimulation in Tourette syndrome: the international Tourette syndrome deep brain stimulation public database and registry. JAMA Neurol. 2018;75:353–359.
   PubMed Web of Science ®Google Scholar
• Marras C, Andrews D, Sime E, et al. Botulinum toxin for simple motor tics: a randomized, double-blind, controlled clinical trial. Neurology. 2001;56:605–610.
   PubMed Web of Science ®Google Scholar
• Woods DW, Conelea CA, Himle MB. Behavior therapy for Tourette’s disorder: utilization in a community sample and an emerging area of practice for psychologists. Prof Psychol. 2010;41:518.
   Google Scholar
• Scahill L, Woods DW, Himle MB, et al. Current controversies on the role of behavior therapy in Tourette syndrome. Mov Disord. 2013;28:1179–1183.
   PubMed Web of Science ®Google Scholar
• Nissen JB, Kaergaard M, Laursen L, et al. Combined habit reversal training and exposure response prevention in a group setting compared to individual training: a randomized controlled clinical trial. Eur Child Adolesc Psychiatry. 2019;28:57–68.
   PubMed Web of Science ®Google Scholar
• Flancbaum M, Rockmore L, Franklin ME. Intensive behavior therapy for tics: implications for clinical practice and overcoming barriers to treatment. J Dev Phys Disabil. 2011;23:61–69.
   Web of Science ®Google Scholar
• Himle MB, Freitag M, Walther M, et al. A randomized pilot trial comparing videoconference versus face-to-face delivery of behavior therapy for childhood tic disorders. Behav Res Ther. 2012;50:565–570.
   PubMed Web of Science ®Google Scholar
• Conelea CA, Wellen BC. Tic treatment goes tech: a review of TicHelper. com. Cognit Behav Pract. 2017;24:374–381.
   PubMed Web of Science ®Google Scholar
• Jakubovski E, Reichert C, Karch A, et al. The ONLINE-TICS study protocol: a randomized observer-blind clinical trial to demonstrate the efficacy and safety of internet-delivered behavioral treatment for adults with chronic tic disorders. Front Psychiatry. 2016;7:119.
   PubMed Web of Science ®Google Scholar
• Andrén P, Aspvall K, de la Cruz LF, et al. Therapist-guided and parent-guided internet-delivered behaviour therapy for paediatric Tourette’s disorder: a pilot randomised controlled trial with long-term follow-up. BMJ Open. 2019;9:e024685.
   PubMedGoogle Scholar
• Singer HS, Rajendran S, Waranch HR, et al. Home-based, therapist-assisted, therapy for young children with primary complex motor stereotypies. Pediatr Neurol. 2018;85:51–57.
   PubMed Web of Science ®Google Scholar
• Specht MW, Mahone EM, Kline T, et al. Efficacy of parent‐delivered behavioral therapy for primary complex motor stereotypies. Dev Med Child Neurol. 2017;59:168–173.
   PubMed Web of Science ®Google Scholar
• Storch EA, De Nadai AS, Lewin AB, et al. Defining treatment response in pediatric tic disorders: a signal detection analysis of the yale global tic severity scale. J Child Adolesc Psychopharmacol. 2011;21:621–627.
   PubMed Web of Science ®Google Scholar
• Jeon S, Walkup JT, Woods DW, et al. Detecting a clinically meaningful change in tic severity in Tourette syndrome: A comparison of three methods. Contemp Clin Trials. 2013;36:414–420.
   PubMed Web of Science ®Google Scholar
• McGuire JF, Storch EA. An inhibitory learning approach to cognitive-behavioral therapy for children and adolescents. Cognit Behav Pract. 2019;26:214–224.
   PubMed Web of Science ®Google Scholar
• McGuire JF, Wu MS, Piacentini J, et al. A meta-analysis of d-cycloserine in exposure-based treatment: moderators of treatment efficacy, response, and diagnostic remission. J Clin Psychiatry. 2017;78:196.
   PubMed Web of Science ®Google Scholar
• McGuire JF, Lewin AB, Storch EA. Enhancing exposure therapy for anxiety disorders, obsessive-compulsive disorder and post-traumatic stress disorder. Expert Rev Neurother. 2014;14:893–910.
   PubMed Web of Science ®Google Scholar
• Felling RJ, Singer HS. Neurobiology of Tourette syndrome: current status and need for further investigation. J Neurosci. 2011;31:12387–12395.
   PubMed Web of Science ®Google Scholar
• Singer HS, Morris C, Grados M. Glutamatergic modulatory therapy for Tourette syndrome. Med Hypotheses. 2010;74:862–867.
   PubMed Web of Science ®Google Scholar
• Artukoglu BB, Bloch MH. The potential of cannabinoid-based treatments in Tourette Syndrome. CNS Drugs. 2019;33:417–30.
   PubMed Web of Science ®Google Scholar
• Lemmon ME, Grados M, Kline T, et al. Efficacy of glutamate modulators in tic suppression: a double-blind, randomized control trial of D-serine and riluzole in Tourette Syndrome. Pediatr Neurol. 2015;52:629–634.
   PubMed Web of Science ®Google Scholar
• Müller-Vahl KR, Schneider U, Prevedel H, et al. Δ9-tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome: A 6-week randomized trial. J Clin Psychiatry. 2003;64:459-65.
   PubMed Web of Science ®Google Scholar
• Jankovic J, Jimenez-Shahed J, Budman C, et al. Deutetrabenazine in tics associated with Tourette syndrome. Tremor Other Hyperkinet Mov. 2016;6:422-9.
   Web of Science ®Google Scholar
• Niemann N, Jankovic J. Real-world experience with VMAT2 inhibitors. Clin Neuropharmacol. 2019;42:37–41.
   PubMed Web of Science ®Google Scholar
• Jankovic J, Glaze DG, Frost JD. Effect of tetrabenazine on tics and sleep of Gilles de la Tourette’s syndrome. Neurology. 1984;34:688.
   PubMed Web of Science ®Google Scholar
• Jankovic J, Rohaidy H. Motor, behavioral and pharmacologic findings in Tourette’s syndrome. Can J Neurosci Nurs. 1987;14:541–546.
   Google Scholar
• Jankovic J, Orman J. Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias. Neurology. 1988;38:391.
   PubMed Web of Science ®Google Scholar
• Jankovic J, Beach J. Long-term effects of tetrabenazine in hyperkinetic movement disorders. Neurology. 1997;48:358–362.
   PubMed Web of Science ®Google Scholar
• Paleacu D, Giladi N, Moore O, et al. Tetrabenazine treatment in movement disorders. Clin Neuropharmacol. 2004;27:230–233.
   PubMed Web of Science ®Google Scholar
• Sweet RD, Bruun R, Shapiro E, et al. Presynaptic catecholamine antagonists as treatment for Tourette syndrome: effects of alpha methyl para tyrosine and tetrabenazine. Arch Gen Psychiatry. 1974;31:857–861.
   PubMed Web of Science ®Google Scholar
• Vieregge P. Tetrabenazine in the treatment of senile vocal tics. J Neurol. 1987;235:126–127.
   PubMed Web of Science ®Google Scholar
• Grados M, Huselid R, Duque-Serrano L. Transcranial magnetic stimulation in Tourette syndrome: a historical perspective, its current use and the influence of comorbidities in treatment response. Brain Sci. 2018;8:129.
   Web of Science ®Google Scholar
• Storch EA, Morgan JE, Caporino NE, et al. Psychosocial treatment to improve resilience and reduce impairment in youth with tics: an intervention case series of eight youth. J Cognit Psychotherapy. 2012;26:57–70.
   Google Scholar
• McGuire JF, Arnold E, Park JM, et al. Living with tics: reduced impairment and improved quality of life for youth with chronic tic disorders. Psychiatry Res. 2015;225:571–579.
   PubMed Web of Science ®Google Scholar